Fresh analysis indicates that individuals who discontinue new slimming jabs like Mounjaro or Wegovy can put back on reduced body mass at a significantly accelerated pace than those who halt conventional diet and exercise plans.
Research printed in a leading health publication shows that while obese people frequently drop about a fifth of their total mass while using the jabs, the mass comes back at an estimated rate of nearly a kilo each month once they quit.
"People using such drugs should be aware of the risk of rapid rebound weight gain when the therapy concludes," stated expert Dr. Susan Jebb.
This pace of recovery implies a reversion to original weight in about one and a half years.
Comparing Treatments
The study, which reviewed dozens of studies involving over 9,000 of patients, compared the effects of the injectable medications with other pills.
The team note that individuals who shed pounds through dieting generally have a more gradual weight regain—around 0.1 kg a month—post-intervention.
Understanding the Fast Regain
Experts suggest the way of the jabs explains the heightened regain.
The injections imitate a body's own chemical called GLP-1, which helps regulate hunger.
"Sustained high doses of the hormone concentrations several times higher than the body's typical production might result in the body to generate a reduced amount of its own natural hormone, and may also reduce responsiveness to its actions," explained Dr. Adam Collins, a nutrition expert.
"Withdrawal of this medication results in appetite is unsuppressed, making excessive eating far more likely."
An Ongoing Disease?
Medical guidelines recommend the jabs for individuals with weight-linked health risks, accompanied by prescribed diet and exercise modifications.
Many experts contend that, considering the significant potential of relapse, the therapy might need to be life-long.
This view is echoed by pharmaceutical companies, who state that the results "emphasize the chronic nature of excess weight," similar to managing diseases like hypertension.
User Accounts
Individuals who have stopped the jabs report a powerful resurgence of hunger.
"I experienced a switch that goes on and you're instantly starving," recalled one woman.
This challenge is exacerbated if users have not established sustainable dietary or behavioural changes during therapy.
Growing Adoption
Recent estimates indicate that millions of people in the UK have tried these injections in the last 12 months, with demand being substantial.
- Use is higher among females than males.
- The middle-aged demographic shows the greatest usage rates.
- A large proportion obtain the medications through private prescriptions rather than public health services.
Finally, clinicians emphasize that while GLP-1 drugs are powerful tools for shedding pounds, they are not a permanent fix and maintained weight loss relies on ongoing behavioural changes.